Medicines for Malaria Venture – Long-Acting Injectable
Overview
Medicines for Malaria Venture (MMV) developed a target product profile (TPP) to help guide the development of a long-acting injectable (LAI) product for malaria prevention. There are ongoing efforts to develop LAI drugs and the WDI Healthcare team is working to provide insights into the trade-offs between LAI product characteristics from the perspective of key stakeholders in several target countries. The insights generated from this work will help to inform future product development decisions and, if applicable, a revised TPP.